Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

May 14, 2021

BUY
$1.89 - $2.96 $13.1 Million - $20.6 Million
6,942,596 Added 74.17%
16,302,596 $34.7 Million
Q4 2020

Feb 16, 2021

BUY
$0.65 - $1.94 $6.08 Million - $18.2 Million
9,360,000 New
9,360,000 $18.2 Million

Others Institutions Holding VTGN

About VistaGen Therapeutics, Inc.


  • Ticker VTGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 206,836,000
  • Market Cap $623M
  • Description
  • VistaGen Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in developing and commercializing various medicines with the potential to care for anxiety, depression, and other disorders of the central nervous system (CNS). The company's CNS pipeline includes PH94B, a rapid-onset neuroactive nasal spray, which is in Phase III d...
More about VTGN
Track This Portfolio

Track Nea Management Company, LLC Portfolio

Follow Nea Management Company, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nea Management Company, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nea Management Company, LLC with notifications on news.